Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder ...

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

Bitter taste receptors inside cancer cells have been found to be activated in the presence of anti-cancer drugs. Shutting ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

Scientists at St. Jude Children’s Research Hospital identified a binding cleft in nuclear receptors offering alternative drug ...

A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) ...